Author + information
- Alexander Vonbank,
- Christoph H. Saely,
- Philipp Rein,
- Andreas Leiherer,
- Daniela Zanolin and
- Heinz Drexel
Background: The visceral adiposity index (VAI) is a validated tool for the evaluation of visceral adiposity, using waist circumference, serum triglycerides, age and gender to diagnose this metabolic abnormality. It has recently been associated with cardiovascular risk in primary care patients. No data are available on the association of the VAI with mortality in patients with established CAD.
Methods: We therefore calculated the VAI in 1472 consecutive patients with angiographically proven stable CAD according to the Amato formula. T2DM was defined according to the ADA definition. The incidence of vascular events was recorded over 10 years.
Results: At baseline, the VAI was significantly higher in CAD patients with T2DM than in those without diabetes (362±330 vs. 247±224; p <0.001). Prospectively, 539 vascular events occurred; the event rate were significantly higher in patients with T2DM than in those who did not have diabetes (44.8% vs. 33.7%; p<0.001). The VAI significantly predicted cardiovascular events in CAD patients with T2DM (standardized adjusted hazard ratio (HR) 1.16 [1.01-1.33]; p=0.037) as well as in those without T2DM (HR 1.14 [1.02- 1.27]; p=0.018).
Conclusions: We conclude that the VAI predicts cardiovascular events both in CAD patients with and in CAD patients without diabetes.
Poster Hall, Hall C
Saturday, March 18, 2017, 9:45 a.m.-10:30 a.m.
Session Title: Updates on Risk Factors for Cardiovascular Disease
Abstract Category: 32. Prevention: Clinical
Presentation Number: 1187-067
- 2017 American College of Cardiology Foundation